Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis

BACKGROUND/AIMS: Real-world studies assessing the effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) for Child-Pugh B/C hepatitis C virus (HCV)-related cirrhosis are limited. METHODS: We included 107 patients with Child-Pugh B/C HCV-related cirrhosis receiving SOF/VEL...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chen-Hua, Chen, Chi-Yi, Su, Wei-Wen, Liu, Chun-Jen, Lo, Ching-Chu, Huang, Ke-Jhang, Chen, Jyh-Jou, Tseng, Kuo-Chih, Chang, Chi-Yang, Peng, Cheng-Yuan, Shih, Yu-Lueng, Huang, Chia-Sheng, Kao, Wei-Yu, Yang, Sheng-Shun, Tsai, Ming-Chang, Wu, Jo-Hsuan, Chen, Po-Yueh, Su, Pei-Yuan, Hwang, Jow-Jyh, Fang, Yu-Jen, Lee, Pei-Lun, Tseng, Chi-Wei, Lee, Fu-Jen, Lai, Hsueh-Chou, Hsieh, Tsai-Yuan, Chang, Chun-Chao, Chang, Chung-Hsin, Huang, Yi-Jie, Kao, Jia-Horng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524072/
https://www.ncbi.nlm.nih.gov/pubmed/34255961
http://dx.doi.org/10.3350/cmh.2021.0155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524072/
https://www.ncbi.nlm.nih.gov/pubmed/34255961
http://dx.doi.org/10.3350/cmh.2021.0155

Ejemplares similares